Hosted on Zoom (https://zoom.us/download)
PROGRAM AT A GLANCE
Clinical Practice - Challenging the Status Quo
Dr. Shalu Pal, OD, FAAO, FSLS, FBCLA, FIAOMC
Let’s skip all the basics and jump to the good stuff. In this lecture, will explore what’s new in myopia management and what the top controversial issues are. How to decide when to make protocol changes, how to interpret axial length readings and how to convert more patients into a myopia management strategy will all be reviewed. Let’s set the facts straight on uncertain areas of myopia control and dive into whether or not myopia management should be standard of care in optometry.
COPE ID 99595-GO | 1 Hour
Myopia Update 2026
Dr. Vishakha Thakrar, OD, FAAO, FSLS
Novel treatment and management devices for myopia progression are emerging every few months in the areas of glasses, contact lenses, pharmaceuticals and photobiomodulation. This course will review new research on myopia progression and will discuss the latest contact lens and ophthalmic lens technology. A summary on new pharmaceutical research and how to incorporate this information into clinical practice will be presented. We will discuss the controversies in red light therapy and the latest tools and devices used to monitor and diagnose myopia progression.
COPE ID 103640-GO | 1 Hour
Adapting the Optimal Myopia Control Device as the Patient Ages: A Walkthrough to the Mid-Twenties
Dr. Patrick Simard, OD, MSc, MBA, FAAO, Dipl. AAO, FBCLA, FIACLE, FIAOMC, IACMM
This course will review the patient journey from early myopia control intervention, as soon as myopia appears, through the mid-twenties. This course will focus on optimizing the myopia control options, depending on the age and the expectations of the patient, to provide at less a decade of myopia control interventions. An overview of the current toolbox will highlight the efficacy of the anti-myopia glasses, orthokeratology, soft multifocal contact lenses and atropine. Based on the effect on quality of life, the attendees will learn how to anticipate common complications for each modality.
COPE ID 102937-GO | 1 Hour
Atropine and Pharma Treatment for Myopia
Dr. Langis Michaud, OD, MSc, Dipl (AAO), FSLS, FBCLA, FEAOO, IAOMMC
Several strategies can be used to manage myopia and prevent the development of blinding diseases. Among these, atropine can be used as monotherapy or in combination with other optical devices. This course reviews this molecule and attempts to answer questions that practitioners may have, including ‘what is the mechanism of action, what dosage should be used, when should treatment be started and stopped, how can rebound effects be avoided and what are the short, medium and long-term effects?’
COPE ID 103303-PH | 1 Hour
COPE Activity ID Pending
*Program and speakers are subject to change without notice
Authorization for Sharing Contact Information
By purchasing a ticket and registering for this event, the customer acknowledges and agrees that their contact information (including, but not limited to, name, email address, phone number and mailing address) may be shared with our vendors and sponsors. This information may be used for marketing, promotional activities or other communications related to the event. The customer further understands that vendors and sponsors are required to handle their information in accordance with applicable data protection laws, however, the event organizers are not responsible for the actions or policies of these third parties. If you do not wish to have your contact information shared, please contact info@aoece.com prior to completing your registration.
